0 items USD 0.00Search
Your search for "global markets direct mantle cell lymphoma pipeline review h1 2015" gave back 48391 results.
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
Catalog:
La Merie Publishing
June 2022
Price: USD 1,170.00
Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Mantle Cell Lymphoma Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Mantle Cell...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The “Mantle Cell Lymphoma Treatment Industry Forecast” looks at past sales and reviews total world Mantle Cell Lymphoma Treatment sales in 2022,...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Mantle Cell Lymphoma Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Mantle Cell Lymphoma Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Market Analysis and Insights: Global Mantle Cell Lymphoma Treatment Market The global Mantle Cell Lymphoma Treatment market is projected to grow from...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
Highlights The global Mantle Cell Lymphoma Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
Catalog:
La Merie Publishing
July 2022
Price: USD 2,000.00
The “Daratumumab Industry Forecast” looks at past sales and reviews total world Daratumumab sales in 2022, providing a comprehensive analysis by...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Imbruvica market size was valued at US$ million in 2023. With growing demand in downstream market, the Imbruvica is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Highlights The global CAR-T Cell Immunotherapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
